Eurosurveillance banner


Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Edition  2008: Volume 13/ Issue 12 Article 3 Printer friendly version
Back to Table of Contents
Previous Download (pdf) Next

Eurosurveillance, Volume 13, Issue 12, 18 March 2008
Rapid communications
A Framework Action Plan to fight Tuberculosis in the European Union
  1. European Centre for Disease Prevention and Control, Stockholm, Sweden

Citation style for this article: Fernandez de la Hoz K, Manissero D, on behalf of the Tuberculosis Disease Programme*. A Framework Action Plan to fight Tuberculosis in the European Union. Euro Surveill. 2008;13(12):pii=8074. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8074
Many European Union (EU) Member States show a decline in tuberculosis (TB) incidence and many have low incidence rates (15 countries reported less than 10 cases per 100,000 population in 2006). However, despite the progress in curbing the TB epidemic, the disease remains a public health threat in the EU. The epidemiological patterns are still very diverse between countries and control efforts are challenged by problems such as multidrug-resistant (MDR TB) and extensively drug-resistant tuberculosis (XDR TB), TB/HIV co-infection and the concentration of cases within vulnerable groups.

In this context, in March 2007 the EU Health Commissioner called on the European Centre for Disease Prevention and Control (ECDC) to work on a proposal for an action plan to fight TB in the EU. Following the call, the ECDC has developed a Framework Action Plan to fight Tuberculosis in the European Union [1]. The document covers the essential elements that need to be addressed to control TB effectively and finally to eliminate the disease (defined as less than one case per 1,000,000 population) in the EU. It has been developed by the ECDC Tuberculosis Disease Programme, in close collaboration with the European Commission and with the extensive contribution of other experts from ECDC, the EuroTB network, EU Member States and European Economic Area EEA/EFTA countries, the World Health Organization (WHO) and other key stakeholders. In addition, the Round Table on Health Strategies in Europe organized by the Portuguese Presidency of the EU in July 2007 provided valuable expert input on the topic of MDR/XDR TB.

The long-term goal of the Framework Action Plan to fight Tuberculosis in the European Union is to control and ultimately eliminate TB in the EU. Specifically, the plan aims at:

  • Increasing political and public awareness of TB as a public health issue in the EU;
  • Supporting and strengthening EU Member States’ efforts against TB in line with national epidemiological situation and challenges; and
  • Contributing to the control of TB in the EU by supporting those countries from which imported cases originate.
The plan is based on four principles: ensuring prompt and quality care for all; strengthening capacity of health systems; developing new tools; and building partnerships and collaboration with countries and stakeholders. Eight areas for strategic development are linked to the four basic principles described in the document. These eight areas (Box 1) recognise the need to consider the heterogeneous epidemiological picture in the EU and to recognise the different needs of those countries with high, and those with low, TB incidences in order to direct actions appropriately. The four principles and the underpinned strategies are in line with the content of the United Nations’ Millennium Development Goals and the WHO Stop TB Strategy and is complementary to the ‘Plan to Stop TB in 18 High Priority Countries in the WHO European Region 2007–2015’ [1].

The plan is meant as a first step in a process that will need to continue over the coming years with more detailed activities implemented at regional, national and Community level. Close collaboration with countries neighbouring the EU and other countries will be essential in the implementation of this plan in order to contribute to the global reduction of TB. The 'Framework Action Plan to fight Tuberculosis in the European Union' is posted on the ECDC website (http://ecdc.europa.eu/pdf/080317_TB_Action_plan.pdf) and will be presented to the European Council in June 2008.


* Tuberculosis Disease Programme members: A. Amato-Gaucci, K. Fernandez de la Hoz, V. Hollo, C. Kodmon, D. Manissero, A. Nanda, J. O’Toole, A. Ozin, V. Prikazsky, I. Steffens, A. Würz

References

  1. European Centre for Disease Prevention and Control. A Framework Action Plan to fight Tuberculosis in the EU. Stockholm; 2008. Available from http://ecdc.europa.eu/pdf/080317_TB_Action_plan.pdf
  2. World Health Organization. Plan to Stop TB in 18 priority countries of the WHO European Region, 2007–2015. Copenhagen; 2007. Available from: http://www.euro.who.int/document/E91049.pdf

 



Back to Table of Contents
Previous Download (pdf) Next

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved